Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Non-Current Debt (2016 - 2022)

Avanos Medical (AVNS) has disclosed Non-Current Debt for 8 consecutive years, with $226.3 million as the latest value for Q4 2022.

  • Quarterly Non-Current Debt rose 74.08% to $226.3 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $226.3 million through Dec 2022, up 74.08% year-over-year, with the annual reading at $226.3 million for FY2022, 74.08% up from the prior year.
  • Non-Current Debt hit $226.3 million in Q4 2022 for Avanos Medical, up from $130.0 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $542.0 million in Q1 2018 to a low of $130.0 million in Q4 2021.
  • Historically, Non-Current Debt has averaged $269.9 million across 4 years, with a median of $247.6 million in 2018.
  • Biggest five-year swings in Non-Current Debt: tumbled 57.34% in 2018 and later surged 74.08% in 2022.
  • Year by year, Non-Current Debt stood at $247.7 million in 2018, then rose by 0.16% to $248.1 million in 2019, then crashed by 47.6% to $130.0 million in 2021, then soared by 74.08% to $226.3 million in 2022.
  • Business Quant data shows Non-Current Debt for AVNS at $226.3 million in Q4 2022, $130.0 million in Q4 2021, and $248.1 million in Q4 2019.